Bradley Foster & Sargent Inc Merck & Co., Inc. Transaction History

Bradley Foster & Sargent Inc

$5.82 Billion
Q3 2024

A detailed history of Bradley Foster & Sargent Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 419,358 shares of MRK stock, worth $41.6 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares

419,358

Previous 423,697 1.02%

Holding current value

$41.6 Million

Previous $52.5 Million 9.21%

% of portfolio

0.82%

Previous 0.96%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$111.15 - $128.97 $482,279 - $559,600	-4,339 Reduced 1.02%	419,358 $47.6 Million
Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $847,287 - $909,978	-6,844 Reduced 1.59%	423,697 $52.5 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $1.29 Million - $1.51 Million	-11,421 Reduced 2.58%	430,541 $56.8 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $1.48 Million - $1.61 Million	-14,802 Reduced 3.24%	441,962 $48.2 Million
Q2 2023 Aug 08, 2023	SELL	$108.61 - $118.38 $11.3 Million - $12.3 Million	-103,606 Reduced 18.49%	456,764 $52.7 Million
Q1 2023 May 08, 2023	SELL	$102.94 - $114.86 $333,937 - $372,605	-3,244 Reduced 0.58%	560,370 $59.6 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $91,724 - $117,603	1,049 Added 0.19%	563,614 $62.5 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $50,210 - $56,406	594 Added 0.11%	562,565 $48.4 Million
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $117,553 - $133,253	1,408 Added 0.25%	561,971 $51.2 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $32,197 - $36,091	-438 Reduced 0.08%	560,563 $46 Million
Q4 2021 Mar 11, 2022	BUY	$72.28 - $90.54 $394,937 - $494,710	5,464 Added 0.98%	561,001 $43 Million
Q3 2021 Nov 10, 2021	SELL	$71.68 - $78.83 $377,825 - $415,512	-5,271 Reduced 0.94%	555,537 $41.7 Million
Q2 2021 Aug 19, 2021	SELL	$70.31 - $77.77 $995,308 - $1.1 Million	-14,156 Reduced 2.46%	560,808 $43.6 Million
Q1 2021 Apr 26, 2021	SELL	$68.86 - $81.11 $1.47 Million - $1.73 Million	-21,327 Reduced 3.58%	574,964 $44.3 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $1.08 Million - $1.19 Million	14,994 Added 2.58%	596,291 $48.8 Million
Q3 2020 Oct 26, 2020	BUY	$73.18 - $82.95 $316,649 - $358,924	4,327 Added 0.75%	581,297 $48.2 Million
Q1 2020 May 07, 2020	SELL	$63.36 - $87.82 $98,208 - $136,121	-1,550 Reduced 0.27%	576,970 $44.4 Million
Q4 2019 Jan 29, 2020	SELL	$77.58 - $87.54 $130,101 - $146,804	-1,677 Reduced 0.29%	578,520 $52.6 Million
Q3 2019 Oct 30, 2019	SELL	$76.08 - $82.93 $608,335 - $663,108	-7,996 Reduced 1.36%	580,197 $48.8 Million
Q2 2019 Aug 08, 2019	SELL	$69.84 - $81.59 $1.6 Million - $1.87 Million	-22,929 Reduced 3.75%	588,193 $49.3 Million
Q1 2019 May 02, 2019	SELL	$69.58 - $79.36 $801,979 - $914,703	-11,526 Reduced 1.85%	611,122 $50.8 Million
Q4 2018 Jan 30, 2019	SELL	$65.24 - $75.71 $276,813 - $321,237	-4,243 Reduced 0.68%	622,648 $47.6 Million
Q3 2018 Oct 31, 2018	SELL	$57.69 - $67.84 $304,199 - $357,720	-5,273 Reduced 0.83%	626,891 $44.5 Million
Q2 2018 Jul 31, 2018	SELL	$50.83 - $59.72 $867,769 - $1.02 Million	-17,072 Reduced 2.63%	632,164 $38.4 Million
Q1 2018 May 07, 2018	SELL	$50.96 - $59.23 $2.47 Million - $2.88 Million	-48,567 Reduced 6.96%	649,236 $35.4 Million
Q4 2017 Feb 06, 2018	SELL	$51.62 - $61.64 $2.79 Million - $3.33 Million	-54,092 Reduced 7.19%	697,803 $39.3 Million
Q3 2017 Nov 03, 2017	BUY	$58.67 - $63.13 $44.1 Million - $47.5 Million	751,895	751,895 $48.1 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Account

Bradley Foster & Sargent Inc Merck & Co., Inc. Transaction History